» Articles » PMID: 18264872

Consumer Participation in the Planning and Delivery of Drug Treatment Services: the Current Arrangements

Overview
Specialty Psychiatry
Date 2008 Feb 12
PMID 18264872
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction And Aims: Consumer participation in decision-making about service planning is common in certain health services in Australia but is thought to be largely underdeveloped in drug treatment services. This paper (1) describes the current practices within Australian drug treatment services that aim to include consumers in service planning and provision; and (2) determines how much consumers know about the existing opportunities for involvement.

Design And Method: Sixty-four randomly selected service providers (representing 64 separate services) completed interviews about the current arrangements for consumer participation within their services (response rate = 82%). A total of 179 consumers completed interviews assessing their knowledge of the consumer participation activities available at the service they attended.

Results: Consumer participation activities were not uncommon in drug treatment services, although the existing activities were concerned largely with providing information to or receiving information from consumers. Activities that included consumers in higher forms of involvement, such as those in which consumers took part in decision-making, were largely uncommon. Consumers had a considerable lack of knowledge about the participation activities available to them, revealing a lack of communication between providers and consumers.

Conclusions: While service providers were making efforts to engage consumers in service planning and provision (despite the general lack of State or Commonwealth policy directives and extra funding to do so), these appear ineffectual because of poor communication between providers and consumers. As a starting point, a critical part of any meaningful consumer participation initiative must include systems to ensure that consumers know about available opportunities.

Citing Articles

"You'll come in and dose even in a global pandemic": A qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemic.

Conway A, Treloar C, Crawford S, Degenhardt L, Dore G, Farrell M Int J Drug Policy. 2023; 114:103998.

PMID: 36907071 PMC: 9986137. DOI: 10.1016/j.drugpo.2023.103998.


The Impact of COVID-19 on the Delivery of Educational Programs in Native American Communities: Qualitative Study.

Sacca L, Markham C, Hernandez B, Shegog R, Peskin M, Rushing S JMIR Form Res. 2022; 6(4):e32325.

PMID: 35348464 PMC: 9004623. DOI: 10.2196/32325.


Woman and girl-centred care for those affected by female genital mutilation: a scoping review of provider tools and guidelines.

Dawson A, Assifi A, Turkmani S Reprod Health. 2022; 19(1):50.

PMID: 35193606 PMC: 8862274. DOI: 10.1186/s12978-022-01356-3.


"Running myself ragged": stressors faced by peer workers in overdose response settings.

Mamdani Z, McKenzie S, Pauly B, Cameron F, Conway-Brown J, Edwards D Harm Reduct J. 2021; 18(1):18.

PMID: 33573661 PMC: 7877312. DOI: 10.1186/s12954-020-00449-1.


Do women with complex alcohol and other drug use histories want women-only residential treatment?.

Neale J, Tompkins C, Marshall A, Treloar C, Strang J Addiction. 2018; 113(6):989-997.

PMID: 29368436 PMC: 6221094. DOI: 10.1111/add.14131.